£107.98

Springer Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders: 1134 (Advances in Experimental Medicine and Biology, 1134)

Price data checked 2 days ago

View at Amazon

Price History & Forecast

Last 89 days • 89 data points

Historical
Generating forecast...
£107.98 £107.20 £107.37 £107.54 £107.71 £107.88 £108.05 05 February 2026 27 February 2026 21 March 2026 12 April 2026 04 May 2026

Price Distribution

Price distribution over 89 days • 2 price levels

Days at Price
Current Price
87 days 2 days · current 0 22 44 65 87 £107 £108 Days at Price

Price Analysis

Most common price: £107 (87 days, 97.8%)

Price range: £107 - £108

Price levels: 2 different prices over 89 days

Description

Product Description The book recognizes that throughout the scientific, medical, and economic communities, new tests incorporating biomarkers are needed to improve the diagnosis of patients suffering from metabolic disorders. The early identification of those at risk of developing obesity will help to place these individuals on the best treatment course as early as possible for improved treatment outcomes. This will also help to cut costs incurred by the healthcare services. For all of this to occur, new research efforts are needed to identify novel biomarkers that can be used to predict the disease in the presymptomatic stage, for disease monitoring and for prediction of treatment response. It is also possible that new drug targets can be identified using these approaches which, in turn, can lead to the development of new treatment approaches. This volume also includes a series of reviews on biomarker discovery and usage in the study of diseases marked by perturbations in metabolism. It will describe the pros and cons of the various approaches and cover the successes and failures in this important research field. From the Back Cover The book recognizes that throughout the scientific, medical, and economic communities, new tests incorporating biomarkers are needed to improve the diagnosis of patients suffering from metabolic disorders. The early identification of those at risk of developing obesity will help to place these individuals on the best treatment course as early as possible for improved treatment outcomes. This will also help to cut costs incurred by the healthcare services. For all of this to occur, new research efforts are needed to identify novel biomarkers that can be used to predict the disease in the presymptomatic stage, for disease monitoring and for prediction of treatment response. It is also possible that new drug targets can be identified using these approaches which, in turn, can lead to the development of new treatment approaches. This volume also includes a series of reviews on biomarker discovery and usage in the study of diseases marked by perturbations in metabolism. It will describe the pros and cons of the various approaches and cover the successes and failures in this important research field. About the Author Dr Paul C. Guest, Ph.D, is a scientific researcher/writer with 35 years of experience in the fields of metabolic and neurological disorders. This includes experience in both academia and the pharmaceutical industry with the majority of time spent at the University of Cambridge and Merck Sharp & Dohme in the United Kingdom. He has also been affiliated with the University of Campinas in Sao Paulo Brazil since 2015, still focused on advancing the field of biomarkers for neurological disorders such as schizophrenia and Alzheimer’s disease.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
08 April 2019
Listed Since
08 January 2019

Barcode

No barcode data available

Similar Products You Might Like

Biomarkers in Inborn Errors of Metabolism: Clinical Aspects and Laboratory Determination
81% match

Biomarkers in Inborn Errors of Metabolism: Clinical Aspects and Laboratory Determination

Elsevier

£68.59 04 May 2026
Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development
79% match

Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development

Springer

£111.22 04 May 2026
The Metabolic Syndrome: Pharmacology and Clinical Aspects
78% match

The Metabolic Syndrome: Pharmacology and Clinical Aspects

Springer

£122.77 04 May 2026
The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)
78% match

The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)

Springer

£40.29 04 May 2026
Dipeptidyl Aminopeptidases: Basic Science and Clinical Applications: 575 (Advances in Experimental Medicine and Biology, 575)
78% match

Dipeptidyl Aminopeptidases: Basic Science and Clinical Applications: 575 (Advances in Experimental Medicine and Biology, 575)

Springer

£118.13 04 May 2026
Metabolomics: Recent Advances and Future Applications
77% match

Metabolomics: Recent Advances and Future Applications

Springer

£155.55 04 May 2026
The Clinician’s Guide to the Treatment of Obesity (Endocrine Updates)
77% match

The Clinician’s Guide to the Treatment of Obesity (Endocrine Updates)

Springer

£80.64 04 May 2026
Circadian Clock in Brain Health and Disease: 1344 (Advances in Experimental Medicine and Biology, 1344)
76% match

Circadian Clock in Brain Health and Disease: 1344 (Advances in Experimental Medicine and Biology, 1344)

Springer

£75.60 04 May 2026
Mass Spectrometry-Based Approaches for Treating Human Diseases and Diagnostics: 1443 (Advances in Experimental Medicine and Biology, 1443)
76% match

Mass Spectrometry-Based Approaches for Treating Human Diseases and Diagnostics: 1443 (Advances in Experimental Medicine and Biology, 1443)

Springer

£128.45 04 May 2026
Cell Signaling & Molecular Targets in Cancer
75% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 04 May 2026
Advances in Metabolomics
75% match

Advances in Metabolomics

£199.99 04 May 2026
Lipid Metabolism in Tumor Immunity: 1316 (Advances in Experimental Medicine and Biology, 1316)
75% match

Lipid Metabolism in Tumor Immunity: 1316 (Advances in Experimental Medicine and Biology, 1316)

Springer

£106.59 04 May 2026
Molecular Mechanisms in Nutritional Epigenetics: 12 (Epigenetics and Human Health, 12)
75% match

Molecular Mechanisms in Nutritional Epigenetics: 12 (Epigenetics and Human Health, 12)

Springer

£141.13 04 May 2026
Targeting Lysine Demethylases in Cancer and Other Human Diseases: 1433 (Advances in Experimental Medicine and Biology, 1433)
75% match

Targeting Lysine Demethylases in Cancer and Other Human Diseases: 1433 (Advances in Experimental Medicine and Biology, 1433)

Springer

£100.08 04 May 2026
MicroRNAs: Role in Cancer Progression, Diagnostics and Therapy (Advances in Biochemistry in Health and Disease, 34)
75% match

MicroRNAs: Role in Cancer Progression, Diagnostics and Therapy (Advances in Biochemistry in Health and Disease, 34)

Springer

£147.11 04 May 2026
Statistical Analysis of Proteomics, Metabolomics, and Lipidomics Data Using Mass Spectrometry (Frontiers in Probability and the Statistical Sciences)
75% match

Statistical Analysis of Proteomics, Metabolomics, and Lipidomics Data Using Mass Spectrometry (Frontiers in Probability and the Statistical Sciences)

Springer

£118.89 04 May 2026
Oxidative Stress: Human Diseases and Medicine
75% match

Oxidative Stress: Human Diseases and Medicine

Springer

£99.53 04 May 2026
Precision Medicine in Oncology
75% match

Precision Medicine in Oncology

Wiley-Blackwell

£132.63 04 May 2026
Surgical Endocrinopathies: Clinical Management and the Founding Figures
75% match

Surgical Endocrinopathies: Clinical Management and the Founding Figures

Springer

£89.12 04 May 2026
Molekularmedizinische Grundlagen von altersspezifischen Erkrankungen (Molekulare Medizin)
75% match

Molekularmedizinische Grundlagen von altersspezifischen Erkrankungen (Molekulare Medizin)

Springer

£78.69 04 May 2026
Pulmonary Dysfunction and Disease: 934 (Advances in Experimental Medicine and Biology, 934)
75% match

Pulmonary Dysfunction and Disease: 934 (Advances in Experimental Medicine and Biology, 934)

Springer

£73.85 04 May 2026
Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)
75% match

Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)

Springer

£127.59 04 May 2026
Adipose Tissue: Endocrine Functions, Health Implications, and Future Perspectives (Contemporary Endocrinology)
74% match

Adipose Tissue: Endocrine Functions, Health Implications, and Future Perspectives (Contemporary Endocrinology)

Springer

£73.40 04 May 2026
Aging Research―Methodological Issues
74% match

Aging Research―Methodological Issues

Springer

£94.29 04 May 2026